Tirzepatide TFA LY3298176 TFA
| 产品介绍 | Tirzepatide TFA (LY3298176 TFA) 是葡萄糖依赖性胰岛素营养多肽 (GIP) 和胰高血糖素样肽-1 (GLP-1) 受体双重激动剂,有潜力用于 2 型糖尿病的研究。 | ||||||
|---|---|---|---|---|---|---|---|
| 生物活性 | Tirzepatide TFA (LY3298176 TFA) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that is being developed for the treatment of type 2 diabetes. | ||||||
| 体外研究 | |||||||
| 体内研究 | |||||||
| 体内研究 | |||||||
| 性状 | Solid | ||||||
| 溶解性数据 | |||||||
| 运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||
| 储存方式 |
Sealed storage, away from moisture
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) | ||||||
| 参考文献 |

浙公网安备 33010802013016号